维普期刊资源整合服务平台（V6.5）

43篇 您的检索式：作者名="Yonesaka"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin显示文摘	Yonesaka K Tamura K Kurata T		0，，04：	1
2	Small interfering RNA targe-ting survivin sensitizes lung cancer cell with mutant p53 to adriamycin显示文摘	Yonesaka K Tamura K Kurata T	2006	Int Cancer2006，118，4：	1
3	Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin显示文摘	Yonesaka K Tamura K Kurata T		0，，：	1
4	Amplification of EGFR T790M causes resistance to an erreversible EGFR inhibitor显示文摘	Ercan D Zejnullahu K Yonesaka K	2010	Oncogene2010，29，：	1
5	Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin显示文摘	Yonesaka K Tamura K Kurata T	2006	Int J Cancer2006，118，4：	1
6	Small interfening RNA targeting survivin sensitizes lung cancer cell with mutant P53 to adriamycin显示文摘	Yonesaka K Tamura K Kurata T	2006	Int J Cancer2006，118，4：	1
7	Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin显示文摘	Yonesaka K Tamura K Kurata T	2006	Int J Cancer2006，118，4：	1
8	Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin显示文摘	Yonesaka K Tamura K Kurata T	2006	Int J Cancer2006，118，4：	1
9	Activation ofERBB2 signaling causes resistance to the EGFR-directedtherapeutic antibody cetuximab显示文摘	Yonesaka K Zejnullahu K Okamoto I	2011	Sci Transl Med2011，3，99：	1
10	The anti-HER3 antibody patritumab abrogates cetuximab resistancemediated by heregulin in colorectal cancer cells显示文摘	Kawakami H Okamoto I Yonesaka K	2014	Onco-target2014，5，11：	1
11	Small interfering RNA targeting sarvivin sensitizes lung cancer cell with mutant p53 to adriamycin 显示文摘	Yonesaka K Tamura K Kurata T	2005	Int J Cancer2005，118，4：	1
12	Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor显示文摘	ERCAN D ZEJNULLAHU K YONESAKA K		0，，16：	1
13	Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin显示文摘	Yonesaka K Tamura K Kurata T	2006	Int J Cancer2006，118，4：	1
14	Autocrine production of amphiregulin predicts sensitivity to both gefitinib and cetuximab in EGFR wild-type cancers显示文摘	Yonesaka K Zejnullahu K Lindeman N		0，，：	1
15	The anti-HER3 antibody patritumab abrogates cetuximab resistance mediated by heregulin in colorectal cancer cells 显示文摘	Kawakami H Okamoto I Yonesaka K	2014	Oncotarget2014，5，11：	1
16	Amplification of EGFR T790M causes resistance to an erreversihle EGFR inhibitor显示文摘	Ercan D Zejnullahu K Yonesaka K	2010	Oneogene2010，29，：	1
17	Biopsy-proven myocardial sequels in Kawasaki disease with giant coronary aneurysms显示文摘	Yonesaka S Takahashi T Eto S	2010	Cardiol Young2010，20，6：	1
18	Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53to adriamycin显示文摘	Yonesaka K Tamura K Kurata T	2006	Int J Cancer2006，118，4：	1
19	Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin 显示文摘	Yonesaka K Tamurak K Kurata T	2006	Int J Cancer2006，118，4：	1
20	Small interfering ENA targeting survivin sensitizes lung cancer cell with mutant p 53 to adriamycin显示文摘	Yonesaka K Tamura K Kurata T	2006	Int J Oancer2006，118，4：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示